-
2
-
-
1642363501
-
Infections due to emerging and uncommon medically important fungal pathogens
-
Walsh TJ, Groll A, Hiemenz J, et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10 (suppl 1): 48-66.
-
(2004)
Clin Microbiol Infect
, vol.10
, Issue.SUPPL. 1
, pp. 48-66
-
-
Walsh, T.J.1
Groll, A.2
Hiemenz, J.3
-
3
-
-
2342455726
-
Fusarium infection in hematopoietic stem cell transplant recipients
-
Nucci M, Marr KA, Queiroz-Telles F, et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004; 38: 1327-42.
-
(2004)
Clin Infect Dis
, vol.38
, pp. 1327-1342
-
-
Nucci, M.1
Marr, K.A.2
Queiroz-Telles, F.3
-
4
-
-
0030737627
-
Fusarium, a significant emerging pathogen in patients with hematological malignancy: Ten years' experience at a cancer center and implications for management
-
Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematological malignancy: ten years' experience at a cancer center and implications for management. Blood 1997; 90: 999-1008.
-
(1997)
Blood
, vol.90
, pp. 999-1008
-
-
Boutati, E.I.1
Anaissie, E.J.2
-
5
-
-
0037108390
-
Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: Implications for diagnosis and management
-
Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002; 35: 909-20.
-
(2002)
Clin Infect Dis
, vol.35
, pp. 909-920
-
-
Nucci, M.1
Anaissie, E.2
-
6
-
-
0026647959
-
Efficacy of liposomal amphotericin B (Ambisome®) in the eradication of Fusarium infection in a leukaemic patient
-
Cofrancesco E, Boschetti C, Viviani MA, et al. Efficacy of liposomal amphotericin B (Ambisome®) in the eradication of Fusarium infection in a leukaemic patient. Haematologica 1992; 77: 280-3.
-
(1992)
Haematologica
, vol.77
, pp. 280-283
-
-
Cofrancesco, E.1
Boschetti, C.2
Viviani, M.A.3
-
7
-
-
17344368128
-
Amphotericin B lipid complex for invasive fungal infections: Analysis of safety and efficacy in 556 cases
-
Walsh TJ, Hiemenz JW, Seibel NL, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998; 26: 1383-96.
-
(1998)
Clin Infect Dis
, vol.26
, pp. 1383-1396
-
-
Walsh, T.J.1
Hiemenz, J.W.2
Seibel, N.L.3
-
8
-
-
0028218069
-
Successful combined surgical and medical treatment of fusarium infection after bone marrow transplantation
-
Ellis ME, Clink H, Younge D, et al. Successful combined surgical and medical treatment of fusarium infection after bone marrow transplantation. Scand J Infect Dis 1994; 26: 225-8.
-
(1994)
Scand J Infect Dis
, vol.26
, pp. 225-228
-
-
Ellis, M.E.1
Clink, H.2
Younge, D.3
-
9
-
-
0032835908
-
Fusarium infections in patients with severe aplastic anemia: Review and implications for management
-
Girmenia C, Iori AP, Boecklin F, et al. Fusarium infections in patients with severe aplastic anemia: review and implications for management. Haematologica 1999; 84: 114-8.
-
(1999)
Haematologica
, vol.84
, pp. 114-118
-
-
Girmenia, C.1
Iori, A.P.2
Boecklin, F.3
-
10
-
-
0027227955
-
Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex
-
Engelhard D, Eldor A, Polacheck I, et al. Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. Leuk Lymphoma 1993; 9: 385-92.
-
(1993)
Leuk Lymphoma
, vol.9
, pp. 385-392
-
-
Engelhard, D.1
Eldor, A.2
Polacheck, I.3
-
11
-
-
0036784325
-
In Vitro Activities of Investigational Triazoles against Fusarium Species: Effects of Inoculum Size and Incubation Time on Broth Microdilution Susceptibility Test Results
-
Paphitou NL, Ostrosky-Zeichner L, Paetznick VL, et al. In Vitro Activities of Investigational Triazoles against Fusarium Species: Effects of Inoculum Size and Incubation Time on Broth Microdilution Susceptibility Test Results. Antimicrobial Agents and Chemotherapy 2002; 46: 3298-300.
-
(2002)
Antimicrobial Agents and Chemotherapy
, vol.46
, pp. 3298-3300
-
-
Paphitou, N.L.1
Ostrosky-Zeichner, L.2
Paetznick, V.L.3
-
12
-
-
0036205764
-
Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000
-
Pfaller MA, Messer SA, Hollis RJ, et al. Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrobial Agents and Chemotherapy 2002; 46: 1032-7.
-
(2002)
Antimicrobial Agents and Chemotherapy
, vol.46
, pp. 1032-1037
-
-
Pfaller, M.A.1
Messer, S.A.2
Hollis, R.J.3
-
13
-
-
0038556830
-
Voriconazole treatment for less-common, emerging, or refractory fungal infections
-
Perfect JR, Marr KA, Walsh TJ, et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003; 36: 1122-31.
-
(2003)
Clin Infect Dis
, vol.36
, pp. 1122-1131
-
-
Perfect, J.R.1
Marr, K.A.2
Walsh, T.J.3
-
14
-
-
33750605303
-
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B
-
Mar 31; [Epub ahead of print]
-
Stanzani M, Vianelli N, Bandini G, et al. Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B. J Infect 2006 Mar 31; [Epub ahead of print]
-
(2006)
J Infect
-
-
Stanzani, M.1
Vianelli, N.2
Bandini, G.3
|